Number needed to treat (revision 5)
Old revision·06:23, 12 Nov 2024·ForestPlotFinn
| Number needed to treat | |
|---|---|
| Abbreviation | NNT |
| Definition | Reciprocal of the absolute risk reduction |
| Requires | A stated time horizon |
| Counterpart | Number needed to harm |
| Topic infobox · conventions | |
The number needed to treat (NNT) is the number of people who must receive a treatment, rather than the comparator, for one additional person to experience the benefit over a defined period. It is the reciprocal of the absolute risk reduction.[1]
Its value is that it expresses effect on an absolute scale. A relative risk reduction of 20% describes a large benefit where the baseline risk is high and a negligible one where it is low; the number needed to treat carries the baseline risk within it.[1]
It is meaningless without a time horizon. A treatment with a number needed to treat of 50 over one year and one of 50 over five years are very different propositions, and quoting the figure without the period is the commonest error made with it.[1]
Calculation
[edit]\text{NNT} = 1 / (\text{risk}\text{control} - \text{risk}\text{treated})
For SELECT, the primary composite occurred in 8.0% of the placebo group and 6.5% of the semaglutide group over a mean 39.8 months. The absolute risk reduction is 1.5 percentage points, so the number needed to treat is 1/0.015 ≈ 67 over roughly 3.3 years.[2]
The corresponding relative figure — a hazard ratio of 0.80, or a 20% relative reduction — is the same result expressed differently and sounds considerably larger. Neither is wrong; they are the same arithmetic.[1]
References
- ^ a b c d Laupacis A, Sackett DL, Roberts RS. "An assessment of clinically useful measures of the consequences of treatment." New England Journal of Medicine 318(26):1728–1733 (1988). PMID 3374545.
- ^ Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. "Semaglutide and cardiovascular outcomes in obesity without diabetes." New England Journal of Medicine 389(24):2221–2232 (2023). PMID 37952131.